CMXC Cell MedX Corp.

Cell MedX Corp. is a development stage company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include electromedical technology, and ebalance technology for diabetes and related complications The company was founded on March 19, 2010 and is headquartered in Carson City, NV.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.15    OTCQB
As of 01/27/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  
IPO date:  08/29/2013
Outstanding shares:  62,923,063
Average volume:  9,074
Market cap:   $10,023,644
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -10.71
PB ratio:   -3.98
PS ratio:   0.00
Return on equity:   54.76%
Net income %:   -14,870.10%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy